ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for default 登録して無料でリアルタイムの株価、インタラクティブチャート、ライブオプションフローなどを入手してください。
Alexion Pharmaceuticals Inc

Alexion Pharmaceuticals Inc (ALXN)

182.50
0.00
( 0.00% )
更新日時: 09:00:00

個人投資家向けのプロ仕様のツール。

主要統計と詳細

通貨
182.50
買値
183.00
売値
185.00
出来高
-
0.00 日の範囲 0.00
0.00 52 週間の範囲 0.00
前日終値
182.50
始値
-
時刻
最終取引時間
-
平均取引量 (3 か月)
-
財務取引量
-
VWAP
-

ALXN 最新ニュース

Moderna Set to Join S&P 500

Moderna Set to Join S&P 500 PR Newswire NEW YORK, July 15, 2021 NEW YORK, July 15, 2021 /PRNewswire/ -- Moderna Inc. (NASD:MRNA) will replace Alexion Pharmaceuticals Inc. (NASD:ALXN) in the...

Alexion Announces Positive Topline Results from Phase 3 Study of ULTOMIRIS® (ravulizumab-cwvz) in Adults with Generalized My...

– Study met primary endpoint of change from baseline in the Myasthenia Gravis-Activities of Daily Living Profile (MG-ADL) total score at Week 26 – – ULTOMIRIS demonstrated compelling efficacy as...

Honeywell International Inc. to Join the NASDAQ-100 Index Beginning July 21, 2021

NEW YORK, July 14, 2021 (GLOBE NEWSWIRE) -- Nasdaq (Nasdaq: NDAQ) today announced that Honeywell International Inc. (Nasdaq: HON), will become a component of the NASDAQ-100 Index® (Nasdaq: NDX...

Caelum & Alexion Present Additional Phase 2 Data Reinforcing Safety & Tolerability of CAEL-101 in AL Amyloidosis at the Europ...

- Exploratory biomarker analyses suggest possible cardiac disease improvements and renal response - Caelum Biosciences and Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) today announced new Phase 2...

 Alexion Announces FDA Approval of ULTOMIRIS® (ravulizumab-cwvz) for Children & Adolescents with Paroxysmal Nocturnal Hemog...

 – With this approval, ULTOMIRIS is the first and only medicine approved in the U.S. to treat children and adolescents with PNH – – Approval based on interim results from Phase 3 study showing...

Caelum and Alexion Announce Upcoming CAEL-101 Data Presentations at the European Hematology Association Congress 2021

- Accepted abstracts include new Phase 2 safety and tolerability data for CAEL-101 in AL amyloidosis - - Phase 3 studies of CAEL-101 in AL amyloidosis are underway - Caelum Biosciences and...

Alexion Announces Upcoming Data Presentations at the 26th European Hematology Association Virtual Congress

– Long-term data evaluate the effectiveness of ULTOMIRIS® (ravulizumab-cwvz) in reducing the risk of thrombosis in PNH, the primary cause of organ damage and premature death in untreated patients...

Alexion Shareholders Approve Acquisition by AstraZeneca

Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) today announced that its shareholders have voted to adopt and approve the previously announced agreement to be acquired by AstraZeneca at a special...

Alexion Reports First Quarter 2021 Results

1Q21 total revenues of $1,636.5 million, a 13% increase over 1Q20 1Q21 GAAP diluted EPS of $2.86; non-GAAP diluted EPS of $3.52 Completed enrollment in Phase 3 studies of ULTOMIRIS®...

UPDATED Alexion to Report First Quarter 2021 Results on Friday, April 30, 2021

Alexion Pharmaceuticals, Inc. (Nasdaq: ALXN) today announced that the Company will report its financial results for the first quarter ended March 31, 2021 before the US financial markets open on...

期間 †前日比前日比 %始値高値安値平均出来高VWAP
10000000CS
40000000CS
120000000CS
260000000CS
520000000CS
1560000000CS
2600000000CS

ムーバー

すべて表示
  • 出来高
  • 値上がり率
  • 値下がり率
銘柄コード株価出来高
SNTISenti Biosciences Inc
US$ 9.4268
(336.43%)
50.96M
PRZOParaZero Technologies Ltd
US$ 1.955
(57.66%)
48.2M
SGBXSafe and Green Holdings Corporation
US$ 0.7295
(48.88%)
59.09M
PPBTPurple Biotech Ltd
US$ 4.7401
(41.28%)
12.39M
JCSEJE Cleantech Holdings Limited
US$ 1.6299
(36.97%)
9.61M
MONDMondee Holdings Inc
US$ 0.478849
(-32.58%)
562.67k
IFBDInfobird Company Ltd
US$ 2.535
(-23.18%)
186.4k
TDTHTrident Digital Tech Holdings Ltd
US$ 2.115
(-20.19%)
495.79k
SDOTSadot Group Inc
US$ 4.20
(-20.00%)
142.27k
DEVSDevvStream Corporation
US$ 0.7758
(-19.19%)
933.66k
SGBXSafe and Green Holdings Corporation
US$ 0.7295
(48.88%)
59.69M
XTIAXTI Aerospace Inc
US$ 0.05711
(27.19%)
56.18M
RGTIRigetti Computing Inc
US$ 3.2588
(6.85%)
55.37M
SNTISenti Biosciences Inc
US$ 9.4268
(336.43%)
52.11M
PRZOParaZero Technologies Ltd
US$ 1.955
(57.66%)
49.19M

ALXN Discussion

投稿を表示

最近閲覧した銘柄